Table 2.
Prevalence of stroke pre- and post-HU use among participants (n = 228).
| Variables | n (%) |
|---|---|
| Stroke status pre-hydroxyurea use | |
| Yes | 28 (12.3) |
| No | 200 (87.7) |
| Stroke status post-hydroxyurea use | |
| Yes | 6 (2.6) |
| No | 222 (97.4) |
| Range of hydroxyurea used per week in mg (minimum-maximum) 6000 (1000–7000) | |
| Dosage of HU used per week (mg) | |
| <3500 | 59 (25.9) |
| 3500 | 132 (57.9) |
| >3500 | 37 (16.2) |
| Duration of HU use | |
| < 2 years | 132 (57.9) |
| ≥ 2 years | 96 (42.1) |